Clopidogrel Completed Phase 4 Trials for Coronary Artery Disease / Aspirin Resistance Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01159639Dual Antiplatelet Therapy in Patients With Aspirin Resistance Following Coronary Artery Bypass Grafting
NCT01349777Effectiveness of Clopidogrel Resinate in PCI(PRIDE)
NCT01371058Study of Policosanol to Improve Platelet Reactivity After Percutaneous Coronary Stent Implantation (PCI)
NCT00724880Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery.